KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Total Non-Current Liabilities (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Total Non-Current Liabilities for 15 consecutive years, with $368.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 13.55% to $368.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $368.7 million, a 13.55% increase, with the full-year FY2025 number at $368.7 million, up 13.55% from a year prior.
  • Total Non-Current Liabilities was $368.7 million for Q4 2025 at Supernus Pharmaceuticals, roughly flat from $369.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $837.7 million in Q4 2021 to a low of -$403000.0 in Q3 2024.
  • A 5-year average of $478.5 million and a median of $364.4 million in 2023 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: plummeted 100.11% in 2024, then surged 91880.15% in 2025.
  • Supernus Pharmaceuticals' Total Non-Current Liabilities stood at $837.7 million in 2021, then dropped by 6.59% to $782.5 million in 2022, then crashed by 54.66% to $354.8 million in 2023, then fell by 8.47% to $324.7 million in 2024, then grew by 13.55% to $368.7 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Total Non-Current Liabilities are $368.7 million (Q4 2025), $369.9 million (Q3 2025), and $318.5 million (Q2 2025).